logo
  

Danone Considers Sale Of $2 Bln Stake In Yakult Honsha : Report

French dairy giant Danone SA (DANOY.PK) is considering a sale of its 20 percent stake in Japanese dairy-drink producer Yakult Honsha Co., worth about $2 billion, Bloomberg reported citing to people familiar with the matter.

The report indicated that Danone has held internal discussions about a possible disposal. The deliberations are at an early stage and no final decision has been made.

A sale would end the French company's 10-year-old agreement with Yakult, whose probiotic and fermented milk drinks are similar to offerings from Danone. It could also raise cash for potential acquisitions, the report said.

Danone reportedly discussed possible targets including U.S. baby-food maker Mead Johnson Nutrition Co., which is valued at $20.5 billion, at a board meeting last month.

The report said that Danone is also discussing a sale of its medical-nutrition business with potential suitors, including Fresenius SE and several buyout firms.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT